Characteristics of patients aged over 75 years with hepatitis C virus infection treated with direct-acting antivirals in Japan: Evidence based on the nationwide, real-world database in Japan.

Hepatology Research : the Official Journal of the Japan Society of Hepatology
Naohiko MasakiMikio Yanase

Abstract

Direct-acting antivirals (DAAs) have dramatically changed the treatment of chronic hepatitis C. Their high efficacy helps in eradicating hepatitis C virus with few adverse events. Information on real-world use of DAAs therapy in patients aged 75 years and older is inadequate. The Japanese DAAs database was constructed in 2014 as a cooperative system between 18 prefectures. The medical reports filled in by doctors and anonymized at the local government office were collected. The patients' demographic features, viral factors, and treatment characteristics were compared among three groups stratified by age when therapy was initiated: Group A (<60 years old), Group B (60-74 years old), and Group C (≥75 years old). Out of the 22,454 patients whose age upon starting therapy could be identified, 24.8% (n = 5597) belonged to Group C, which was ten times the number in the Japanese Interferon Database. Female patients, advanced stages of liver fibrosis, and past history of hepatocellular carcinoma treatment were significantly higher in the older age groups (Group A < B < C), whereas sustained virologic response (SVR) rates were not different (91%-93%). In Group C, multivariate logistic regression analysis revealed that predicting factors...Continue Reading

References

May 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard K SterlingUNKNOWN APRICOT Clinical Investigators
Jan 4, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yu ShimoyamaKatsuaki Tanaka
Mar 8, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hiromitsu KumadaEric Hughes
Feb 4, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kazuaki ChayamaHiromitsu Kumada
Jun 20, 2015·BMC Public Health·Naohiko MasakiUNKNOWN prefectural members contributing to the Japanese Interferon Database
May 5, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Eiichi OgawaUNKNOWN Kyushu University Liver Disease Study(KULDS) Group
Oct 30, 2016·Antiviral Research·Eiichi OgawaUNKNOWN Kyushu University Liver Disease Study (KULDS) Group
Nov 22, 2016·Journal of Gastroenterology and Hepatology·D Steven FoxJeffrey S McCombs
Jun 20, 2017·Journal of Hepatology·Hiroko NagataUNKNOWN Ochanomizu Liver Conference Study Group
Sep 3, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hidenori ToyodaHiromitsu Kumada
Oct 20, 2018·Journal of Hepatology·Mizuki Nishibatake KinoshitaKazuhiko Koike
Jan 9, 2019·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Hideyuki TamaiKatsuhiko Higashi
Nov 21, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hiroko SetoyamaTatsuya Kanto
Dec 10, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marc G GhanyUNKNOWN AASLD-IDSA Hepatitis C Guidance Panel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
Kosuke IshidaShuichi Kaneko
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
X LiuJ Q Niu
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Z W ChenH Ren
Journal of Ayub Medical College, Abbottabad : JAMC
Muhammad UmarMuhammad Osama
© 2021 Meta ULC. All rights reserved